|
1
|
Jamdade VS, Sethi N, Mundhe NA, Kumar P,
Lahkar M and Sinha N: Therapeutic targets of triple-negative breast
cancer: A review. Br J Pharmacol. 172:4228–4237. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nagini S: Breast cancer: Current molecular
therapeutic targets and new players. Anticancer Agents Med Chem.
17:152–163. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li ZJ and Cho CH: Development of peptides
as potential drugs for cancer therapy. Curr Pharm Des.
16:1180–1189. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yang L, Cui Y, Shen J, Lin F, Wang X, Long
M, Wei J and Zhang H: Antitumor activity of SA12, a novel peptide,
on SKBr-3 breast cancer cells via the mitochondrial apoptosis
pathway. Drug Des Devel Ther. 9:1319–1330. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang L, Liu H, Long M, Wang X, Lin F, Gao
Z and Zhang H: Peptide SA12 inhibits proliferation of breast cancer
cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle
arrest. OncoTargets Ther. 11:2409–2417. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bodenstine TM and Welch DR: Metastasis
suppressors and the tumor microenvironment. Cancer Microenviron.
1:1–11. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bohl CR, Harihar S, Denning WL, Sharma R
and Welch DR: Metastasis suppressors in breast cancers: Mechanistic
insights and clinical potential. J Mol Med (Berl). 92:13–30.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Robert J: Biology of cancer metastasis.
Bull Cancer. 100:333–342. 2013.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
10
|
Khan I and Steeg PS: Metastasis
suppressors: Functional pathways. Lab Invest. 98:198–210.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shen T, Zhang K, Siegal GP and Wei S:
Prognostic value of E-cadherin and β-catenin in triple-negative
breast cancer. Am J Clin Pathol. 146:603–610. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hajra KM and Fearon ER: Cadherin and
catenin alterations in human cancer. Genes Chromosomes Cancer.
34:255–268. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Behrens J and Birchmeier W: Cell-cell
adhesion in invasion and metastasis of carcinomas. Cancer Treat
Res. 71:251–266. 1994.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ashaie MA and Chowdhury EH: Cadherins: The
superfamily critically involved in breast cancer. Curr Pharm Des.
22:616–638. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li Z, Yin S, Zhang L, Liu W and Chen B:
Prognostic value of reduced E-cadherin expression in breast cancer:
A meta-analysis. Oncotarget. 8:16445–16455. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shiozaki H, Tahara H, Oka H, Miyata M,
Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M, et
al: Expression of immunoreactive E-cadherin adhesion molecules in
human cancers. Am J Pathol. 139:17–23. 1991.PubMed/NCBI
|
|
19
|
Oka H, Shiozaki H, Kobayashi K, Inoue M,
Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S,
Takeichi M, et al: Expression of E-cadherin cell adhesion molecules
in human breast cancer tissues and its relationship to metastasis.
Cancer Res. 53:1696–1701. 1993.PubMed/NCBI
|
|
20
|
Sawada K, Mitra AK, Radjabi AR, Bhaskar V,
Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A,
Kenny HA, et al: Loss of E-cadherin promotes ovarian cancer
metastasis via α 5-integrin, which is a therapeutic target. Cancer
Res. 68:2329–2339. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bremnes RM, Veve R, Hirsch FR and Franklin
WA: The E-cadherin cell-cell adhesion complex and lung cancer
invasion, metastasis, and prognosis. Lung Cancer. 36:115–124.
2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Novak M, Jarrett SG, McCorkle JR, Mellon I
and Kaetzel DM: Multiple mechanisms underlie metastasis suppressor
function of NM23-H1 in melanoma. Naunyn Schmiedebergs Arch
Pharmacol. 384:433–438. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Steeg PS, Bevilacqua G, Pozzatti R, Liotta
LA and Sobel ME: Altered expression of NM23, a gene associated with
low tumor metastatic potential, during adenovirus 2 Ela inhibition
of experimental metastasis. Cancer Res. 48:6550–6554.
1988.PubMed/NCBI
|
|
24
|
Han W, Zhang C, Cao FY, Cao F, Jiang L and
Ding HZ: Prognostic and clinicopathological value of NM23
expression in patients with breast cancer: A systematic review and
meta-analysis. Curr Probl Cancer. 41:80–93. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fang M, Tao Y, Liu Z, Huang H, Lao M,
Huang L and Zhu B: Meta-analysis of the relationship between NM23
expression to gastric cancer risk and clinical features. BioMed Res
Int. 2017(8047183)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ouatas T, Salerno M, Palmieri D and Steeg
PS: Basic and translational advances in cancer metastasis: Nm23. J
Bioenerg Biomembr. 35:73–79. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Steeg PS, de la Rosa A, Flatow U,
MacDonald NJ, Benedict M and Leone A: Nm23 and breast cancer
metastasis. Breast Cancer Res Treat. 25:175–187. 1993.PubMed/NCBI View Article : Google Scholar
|
|
28
|
MacDonald NJ, de la Rosa A and Steeg PS:
The potential roles of nm23 in cancer metastasis and cellular
differentiation. Eur J Cancer. 31A:1096–1100. 1995.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Salerno M, Palmieri D, Bouadis A,
Halverson D and Steeg PS: Nm23-H1 metastasis suppressor expression
level influences the binding properties, stability, and function of
the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast
carcinoma cells. Mol Cell Biol. 25:1379–1388. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen X, Xu Z and Wang Y: Recent advances
in breast cancer metastasis suppressor 1. Int J Biol Markers.
26:1–8. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kodura MA and Souchelnytskyi S: Breast
carcinoma metastasis suppressor gene 1 (BRMS1): Update on its role
as the suppressor of cancer metastases. Cancer Metastasis Rev.
34:611–618. 2015.PubMed/NCBI View Article : Google Scholar
|
